EBS Operating Cash Flow
Emergent Biosolutions Inc · Operating Cash Flow
EBS Operating Cash Flow
Latest reported$97.70Mperiod ending
EBS TTM Operating Cash Flow ($55.45M → $97.70M)
TTM operating cash flow
High-resolution chart · PNG
EBS operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 97,700,000 | |
| 148,000,000 | |
| 170,600,000 | |
| 13,000,000 | |
| 169,000,000 | |
| 110,100,000 | |
| 58,700,000 | |
| 170,700,000 | |
| 77,000,000 | |
| -84,900,000 | |
| -206,300,000 | |
| -145,600,000 | |
| -279,600,000 | |
| -180,800,000 | |
| -34,100,000 | |
| 202,100,000 | |
| 292,800,000 | |
| 278,700,000 | |
| 321,100,000 | |
| 237,200,000 | |
| 325,700,000 | |
| 483,300,000 | |
| 536,000,000 | |
| 413,000,000 | |
| 304,700,000 | |
| 141,000,000 | |
| 188,000,000 | |
| -99,864,000 | |
| 77,209,000 | |
| 147,591,000 | |
| 41,800,000 | |
| 286,515,000 | |
| 146,057,000 | |
| 165,477,000 | |
| 208,139,000 | |
| 120,014,000 | |
| 113,477,000 | |
| 57,363,000 | |
| 53,487,000 | |
| 65,731,000 | |
| 143,512,000 | |
| 148,127,000 | |
| 44,459,000 | |
| 93,210,000 | |
| 67,374,000 | |
| 75,690,000 | |
| 112,318,000 | |
| 69,138,000 | |
| 50,340,000 | |
| 72,349,000 | |
| 96,968,000 | |
| 46,341,000 | |
| 33,113,000 | |
| 19,197,000 | |
| 39,643,000 | |
| 120,193,000 | |
| 78,132,000 | |
| 52,468,000 | |
| 14,593,000 | |
| 207,000 | |
| 49,543,000 | |
| 60,087,000 | |
| 99,543,000 | |
| 52,078,000 | |
| 31,242,000 | |
| 73,358,000 | |
| 30,511,000 | |
| 41,859,000 | |
| 28,466,000 | |
| -13,101,000 | |
| 7,317,000 | |
| 98,398,000 | |
| 68,347,000 | |
| 35,633,000 | |
| 55,447,000 | |
| -19,630,000 |